IMPACT BIOMEDICAL (IBO) stock: insider trades, news & valuation
Heavy sellingShare price and insider trades
IMPACT BIOMEDICAL insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 3 sold $148K of IBO stock on the open market.
Get emailed when insiders cluster-buy stocks like IBO
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
IBO insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $2K | 3 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | — | 0 | $58K | 3 |
| Q4 2025 | — | 0 | — | 0 |
| Q3 2025 | — | 0 | — | 0 |
| Q2 2025 | — | 0 | $88K | 2 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 IMPACT BIOMEDICAL INC. insiders reported open-market purchases totaling $0, while 3 insiders reported sales totaling $148K. 0 of 8 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 24SEC | Dss, Inc.10% Owner | Sell | 156589,518 held (−0%) | $7.06 | $1K | -39.8% | — |
| Sep 24SEC | Dss, Inc.10% Owner | Sell | 723589,701 held (−0%) | $0.55 | $398 | +672.7% | — |
| Sep 24SEC | Dss, Inc.10% Owner | Sell | 27589,674 held (−0%) | $6.95 | $188 | -38.8% | — |
| Mar 30SEC | Todd D MackoCFO | Sell | 43,400155,122 held (−22%) | $0.56 | $24K | +658.9% | — |
| Mar 30SEC | Todd D MackoCFO | Sell | 1,600198,122 held (−1%) | $0.60 | $960 | +608.3% | — |
| Mar 25SEC | Jason GradyDirector | Sell | 50,000250,182 held (−17%) | $0.65 | $32K | +553.8% | — |
| Jan 6SEC | Dss, Inc.10% Owner | Sell | 115,600590,424 held (−16%) | $0.55 | $64K | +672.7% | — |
| Jan 6SEC | Dss, Inc.10% Owner | Sell | 45,400545,024 held (−8%) | $0.54 | $25K | +687.0% | — |
Insiders at IMPACT BIOMEDICAL INC.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Dss, Inc.10% Owner | — | $90K | Sep 24, 2026 | — |
| Jason GradyDirector | — | $32K | Mar 25, 2026 | — |
| Todd D MackoCFO | — | $25K | Mar 30, 2026 | — |
IBO stock: common questions
Are IMPACT BIOMEDICAL INC. insiders buying IBO stock?
In the past 12 months, 0 insiders reported open-market purchases of IBO worth $0.
Are IMPACT BIOMEDICAL INC. insiders selling IBO stock?
3 insiders reported sales worth $148K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is IBO's 52-week range?
Over the past year IBO has traded between $4.11 and $9.87. It last closed at $4.25 on Oct 9, 2026.